The Merkel Cell Carcinoma Collaborative Institute, also known as MC3, is led by the chair of UW Medicine’s department of dermatology, Paul Nghiem, MD, PhD, according to a Jan. 30 news release from the university.
The collaborative comprises about 50 members across 15 institutions with access to more than 60,000 biological specimens and a clinical database of information from more than 1,900 patients.
Dr. Ngheim anticipates the institute will serve as a “virtual meeting place” for research collaboration, with hopes of awarding grants to member labs in the future, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
